BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantCC
Catalio Capital Management
Activity from announced rounds
Activity in this selectionstonecourt-capital-8e17ee1c
- Rounds participated in
- 8
- Confirmed lead rounds
- 1 6 roles undisclosed
- New companies
- 8 First participation on record · 0 follow-on
- Funding in participating rounds
- $969M 8 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in this selectionEvvy
Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.
$40MSeries B
LeadRatio Therapeutics
Developing best-in-class radiopharmaceuticals for cancer treatment
$70MSeries C
Role not disclosedAdvanCell
Develops lead-212 targeted alpha therapies to treat cancer
$315MSeries D
Role not disclosed9amHealth
AI-enabled virtual specialty care platform for managing high-cost chronic conditions
$26MSeries B
Role not disclosedImperative Care
Develops treatments for patients suffering from thromboembolic disease
$100MGrowth
Role not disclosedProSomnus Sleep Technologies
Provides non-CPAP alternative for Obstructive Sleep Apnea treatment
$38MStrategic
Role not disclosedParabilis Medicines
Develops medicines targeting historically undruggable protein targets in cancer
$305MSeries F
Role not disclosed